Medgenics Inc

Directors Dealings

RNS Number : 1777T
Medgenics Inc
15 November 2013



Press Release

15 November 2013



Directors Dealings


Medgenics, Inc. (AIM: MEDU, MEDG and NYSE MKT: MDGN), the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that, on 11 November 2013 it was informed by Dr. Sol Barer, Chairman of the Board of Directors of the Company, that he purchased on the open market 25,000 shares of common stock on that day at an average price of $6.8049 per share.


Following this purchase, Dr. Barer now owns 72,000 shares of common stock, which represents approximately 0.4 percent of the total issued shares of common stock.  Dr. Barer, directly or through trusts for the benefit of Dr. Barer and his family, also has the right to purchase up to 1,315,000 shares of common stock pursuant to options previously granted (in aggregate Dr. Barer's shares of common stock and options represent 1,387,000 shares of common stock which represent approximately 7.5 percent of the Company's total issued shares of common stock).


This announcement is being made pursuant to the London Stock Exchange's AIM Rules for Companies admitted to trading on the AIM market.



About Medgenics


Medgenics is developing and commercializing Biopump™, a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient's own tissue for the treatment of a range of chronic diseases including anemia, hepatitis, among others.  For more information, please visit




Medgenics, Inc.

John Leaman, CFO

[email protected]


Abchurch Communications

Joanne Shears / Jamie Hooper / Harriet Rae

[email protected]


+44 207 398 7718


Oriel Securities (NOMAD & Joint Broker)

Jonathan Senior / Giles Balleny


+44 207 710 7617 


SVS Securities plc (Joint Broker)

Alex Brearley


+44 203 700 0100





This information is provided by RNS
The company news service from the London Stock Exchange